Astragalus is venturing in Biosimilar drugs The company has expertise in cloning, protein expressions, clone development, cell banking ant its characterization, stable and high-yielding clones, developing upstream and downstream processes for recombinant proteins, product development and characterization We facilitate with molecular biology, upstream, downstream and analytical lab. Molecules in pipeline are related to the treatement of anti cancer, myocardial infarction, anti viral, anti diabetic, hormonal therapy, ranibizumab, urate oxidase, streptokinase, PTH and human growth hormone etc. We have expert scientist to develop and produce the probiotics for animals, aqua culture, poultry and other industrial enzymes production